July 30, 2020 – PharmLabs, First Hemp Lab in Texas, Selects Medicinal Genomics for Microbial Testing Medicinal Genomics Corp. (MGC), a pioneer in harnessing cannabis genomics to improve the agricultural productivity, safety and transparency of cannabis, today announced that PharmLabs, a multistate testing lab organization, has selected Medicinal Genomics’ PathoSEEK® qPCR platform for microbial testing in its Texas hemp lab, the first in that state.

May 05, 2020 – Medicinal Genomics to Launch Medical Practicum at CannMed 2020 The biggest barrier to using medicinal cannabis is that the endocannabinoid system and its related pathologies are not taught in medical school, and as a result, physicians cannot help their patients use cannabis as an effective and safe medication

April 2, 2020 – Medicinal Genomics to Donate a Portion of CannMed Tickets Sales to COVID-19 Response Premier medical & scientific cannabis conference to contribute 10% of ticket sales to support CDC Emergency Response Fund to help mitigate the public health threat

March 10, 2020 – Medicinal Genomics Signs on as Agilent US Value Added Reseller MGC will sell Agilent’s Aria qPCR instruments and Bravo, Agilent’s liquid handling DNA purification and lab automation platform in the U.S

March 9, 2020 – Revolutionizing cannabis cultivation with world-first SNP chip The SNP chip will serve as a powerful research tool for cannabis cultivation, enabling more discoveries of quantitative traits and expanding the diversity of cannabis cultivars assessed in genetic prediction.

February 27, 2020 – Medicinal Genomics Announces New PathoSEEK® Aspergillus Multiplex Assay to Streamline Cannabis Testing New 5-color assay independently identifies four species of pathogenic Aspergillus plus a cannabis control in just one qPCR reaction

January 30, 2020 – Medicinal Genomics Expands Global Reach with Distribution Partners in South America and Southeast Asia Leading genomics firm driving adoption of biotechnology to improve cannabis production in geographies around the world

January 6, 2020 – Medicinal Genomics Partners with Analogic Solutions for Distribution of its Cannabis Genomic Breeding, Optimization, and Testing Platform to the Caribbean Leading local firm driving adoption of biotechnology for yield, safety, and consistency throughout the region

December 10, 2019 – Eurofins Scientific, Medicinal Genomics Partner on World’s Most Comprehensive, Informative Cannabis SNP Chip New SNP chip will help breeders create hemp cultivars that meet new USDA regulations.

November 15, 2019 – Medicinal Genomics Signs Tagaca SRL as Distribution Partner for its Genomic Breeding and Testing Platform in Uruguay Major Uruguay biotech distributor sees global potential for their country’s cannabis crop.

September 10, 2019 – Medicinal Genomics, Arbor Biosciences Partner on Marker Discovery and Genotyping in Cannabis Together the organizations will generate a comprehensive panel for analyzing unique genetic signatures in cannabis strains.

August 20, 2019 – Medicinal Genomics Announces Raphael Mechoulam, the Father of Cannabis Research, Will Headline CannMed 2019, September 23-24, in Pasadena, CA Professor Mechoulam, who co-created CannMed, will keynote its fourth annual gathering along with more than 50 of the greatest minds in cannabis

April 29, 2019 – Medicinal Genomics Partners with Eldan to Distribute its Cannabis Testing and Genomics Solutions to the Israeli Market Israel’s Leading Distributor To Begin Supplying Israel’s Rapidly Growing Medicinal Cannabis Industry with MGC’s Cutting Edge U.S. Technology

April 18, 2019 – Medicinal Genomics announces Cannabis Pan-Genome project, a major advance in genetics for cannabis breeding Pacific Biosciences Sequel II System genetic analysis platform to catalog structural variants—the genetic hotspots—governing cannabis chemotype

January 22, 2019 – Medicinal Genomics Releases Industry’s First Comprehensive Cannabis Reference Genome Genetic milestone in mapping the cannabis genome to be made public to accelerate research and commercialization

January 3, 2019 – Medicinal Genomics Partners with Eiken Chemical for Cannabis Testing to Drive Higher Yield, Ag Productivity Integrating LAMP technology with MGC proprietary genetics accelerates accurate detection of cannabis genes, genotypes, pests and pathogens

October 17, 2018 – CannMed 2018, Country’s Premier Medical Cannabis Conference, Opens October 22nd – 24th at UCLA Luskin Center Third Annual Conference moves west to reflect growing importance of California’s cannabis market, opens with Career Fair hosted by California’s EDD

October 11, 2018 – California Employment Development Department and CannMed 2018 host inaugural Cannabis Career Fair EDD to showcase administrative services, business assistance and more than 75 cannabis companies hiring at 3rd Annual CannMed Medical Cannabis Conference

July 24, 2018 – CannMed 2018 Conference Features the Greatest Minds in Cannabis Research, Medicine, and Cultivation The 3rd Annual CannMed event features global industry leaders, physicians, clinicians, scientists, policy makers, laboratory professionals, attorneys, blockchain leaders, and media, gathering to discuss developments in cannabis medicine, legalization, opioids treatment through cannabis, pain management, cryptocurrency technology, and more.

January 16, 2018 – Medicinal Genomics Partners with DASH Cryptocurrency for CannMed 2018 Cannabis Conference The 3rd Annual CannMed Conference will join leaders in cannabis research, medicine, and technology to discuss the use of cannabis-based therapies for a variety of medical conditions, innovations in cultivation, and the intersection of cryptocurrency and cannabis.

March 30, 2017 – CannMed 2017 Premier Medical Marijuana Conference to Feature Global Industry Leaders, Physicians, Scientists, Politicians, Athletes, Attorneys, and Media Gathering to Discuss Medicine, Legalization, Opioids vs. Cannabis, Pain Management, and More Conference to Be Live Streamed Including Featured Speakers, Dr. Raphael Mechoulam (The “Father of Cannabis Research”), Dr. Michael Dor, Dr. Bonni Goldstein, and Former NFL Athletes

March 28, 2017 – CannMed 2017 Conference will Host Red-Carpet Event and Screening of Film in Honor of Local Teen with Rare Cancer Local Teenage Patient Fulfilled Dream of Becoming a Filmmaker with Help from Hollywood A-List Actors and Directors and the Make A Film Foundation

March 22, 2017 – CannMed 2017 Conference to Feature Former NFL Players Leading Panel Discussion on Medical Marijuana Use in Professional Sports Former NFL players Ricky Williams, Nate Jackson, Eben Britton, and Lance Johnstone join leading physicians to discuss medical cannabis as a viable alternative to often addictive opiates

February 23, 2017 – Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S. Patent targets personalized medicine approach matching genetic markers for chronic pain with therapeutic drugs, including the cannabis-derived compound cannabidiol

February 10, 2017 – CannMed 2017 Conference Announces Expanded Speaker List for Medical Cannabis Health and Research Conference to be Held in Boston in April Leaders in Cannabis Medicine and the Medical Cannabis Industry Join Presenters Including Dr. Raphael Mechoulam, Pioneering Israeli Scientist Known as “The Father of Marijuana Research”

February 3, 2017 – Medicinal Genomics Hosts CannMed 2017 Conference in Boston with Hawaiian Connection International conference at Harvard organized by Manoa Valley resident helps to educate physicians about use of medical cannabis

January 25, 2017 – Medicinal Genomics Receives NIDA Grant to Develop Novel Toxin Detection Test for Medical Cannabis Test development will center around detecting presence of toxic products left behind by rogue molds and bacteria on medical cannabis.

January 12, 2017 – CannMed 2017 Conference to Offer Doctors an Opportunity to Earn CME Credits to Learn About Cannabis Medicine Courtagen and TheAnswerPage partner to provide continuing medical education about the endocannabinoid system and medical cannabis for the CannMed 2017 Personalized Cannabinoid Medicine Conference.

January 9, 2017 – Veterans for Cannabis Foundation and Medicinal Genomics Pair Up to Tackle Medical Marijuana “Strain Name Game” for Vets MGC will provide StrainSEEK® strain identification and registration services for VFCF’s branded products and help promote the VFCF mission as MGC’s exclusive veteran’s cannabis support partner.

December 1, 2016 – Medicinal Genomics and Courtagen Life Sciences Announce CannMed 2017, the Personalized Cannabinoid Medicine Conference, April 9-11, 2017 The 2nd annual CannMed 2017 Conference will convene leaders in research, medicine, and therapeutics to discuss cannabis-based therapies for cancer, and neurological and inflammatory disorders, and developments in cannabis genetics and safety.

November 15, 2016 – Researchers Find Alarming Pathogenic Contamination Inaccuracies with Commonly Used Culture-Based Cannabis Testing Methods Medicinal Genomics (MGC) and Courtagen Life Sciences today announced the publication of a new research study that identifies several significant shortcomings of traditional culture-based safety testing methods for yeast and mold in the Cannabis industry.

October 6, 2016 – Medicinal Genomics Partners with Industry Leaders to Ensure the Safety and Effectiveness of Medical Cannabis Medicinal Genomics, an innovative molecular information company focused on safety, research, and genetics of therapeutic plants, is partnering with a preliminary group of twelve leading cultivators and processors to develop fully-validated, genomics-based safety and quality standards for medical cannabis.

April 20, 2016 – Medicinal Genomics Revolutionizes Cannabis Industry with Introduction of Strain ID & Certification Service Medicinal Genomics Corporation today announced StrainSEEK®, a revolutionary genetics based service designed to identify and certify cannabis and hemp strains, providing growers with the identity, heritage, and chemistry of the cannabis and hemp plants they are cultivating.

April 6, 2016 – CannMed 2016 Conference to be Live Streamed Including the Keynote Speech by Noted Israeli Marijuana Research Pioneer Dr. Raphael Mechoulam Medicinal Genomics and Courtagen Life Sciences today announced that the entire full day program of CannMed 2016 will be live streamed on Monday, April 11th, 2016.

March 15, 2016 – Dr. Raphael Mechoulam to Receive Lifetime Achievement Award at CannMed 2016 Conference in Cambridge, MA in April Pioneering Israeli Scientist Known as “The Father of Marijuana Research,” Dr. Raphael Mechoulam, to be Honored for Decades of Discoveries.

March 8, 2016 – Courtagen and Medicinal Genomics Announce Expanded Speaker List for CannMed 2016 – 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April The conference will feature internationally recognized thought leaders, scientists, physicians, and advocates working to advance research into the endocannabinoid system and cannabinoid therapeutics.

February 11, 2016 – CannMed2016 Announces That Kyle Turley, Former NFL Pro Bowler and Leading Cannabis Advocate, Will Speak at 1st Annual Cannabis Medical Research Conference Being Held in Cambridge, MA in April Former All-Pro NFL offensive lineman, Kyle Turley, will be a featured speaker at CannMed2016. This first annual Personalized Cannabinoid Medicine Conference will be held at The Joseph B. Martin Conference Center at The Harvard School of Medicine April 10-11, 2016.

January 13, 2016 – Medicinal Genomics Corporation and Courtagen Life Sciences Announce CannMed 2016, the Personalized Cannabinoid Medicine Conference, April 10-11, 2016 CannMed 2016 Personalized Cannabinoid Medicine Conference will convene leaders in research, medicine, and therapeutics to discuss real-world issues around cannabis-based therapies for neurological disorders

April 16, 2015 – Medicinal Genomics Corporation Launches PathogINDICAtor®, A Novel and Automated Microbial Screening Kit for Cannabis Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of PathogINDICAtor®, a highly robust and automated microbial screening assay for cannabis.

March 31, 2015 – Medicinal Genomics Corporation Launches SenSATIVAx®, A Novel Automated Plant/Microbial DNA Purification Kit for Cannabis Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of SenSATIVAx®, a highly robust and automated microbial DNA purification kit for Cannabis.

January 12, 2012 – Medicinal Genomics Introduces an iPad App to Explore the Science of Medical Marijuana Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced the availability of Jane-Ome, an application designed for Apple’s iPad tablet, which offers a science based dissection of medical marijuana.

January 15, 2011 – Medicinal Genomics Sequences the Cannabis Genome to Assemble the Largest Known Gene Collection of this Therapeutic Plant Medicinal Genomics Corporation, a pioneer in the genomics of medicinal plants, today announced that the company has sequenced the entire genome of Cannabis Sativa and Cannabis Indica, assembling the largest known gene collection of this therapeutic plant. The DNA purification was performed at the company’s research facility in Amsterdam, and the sequencing was conducted by several service providers, including the latest long read technology from Roche’s 454 sequencing center.